Schweikert, Bernd

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK. [electronic resource] - PharmacoEconomics - open Dec 2020 - 635-648 p. digital

Publication Type: Journal Article

2509-4254

10.1007/s41669-020-00202-1 doi